{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:31:51Z","timestamp":1789619511566,"version":"build-2803163510"},"reference-count":78,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pharmaceutical Development and Technology"],"published-print":{"date-parts":[[2025,3,16]]},"DOI":"10.1080\/10837450.2025.2472887","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T07:44:11Z","timestamp":1740555851000},"page":"280-294","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Engineering orally disintegrating tablets for buccal delivery of cilostazol with enhanced dissolution and bioavailability: a novel dual porogenic approach,\n            <i>in\u00a0vitro<\/i>\n            characterization, and\n            <i>in\u00a0vivo<\/i>\n            evaluation in rats"],"prefix":"10.1080","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8980-4619","authenticated-orcid":false,"given":"Shahinaze A.","family":"Fouad","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Ahram Canadian University","place":["Giza, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Abdelaziz","sequence":"additional","affiliation":[{"name":"National Cancer Institute - Breast Cancer Hospital","place":["Cairo, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud H.","family":"Teaima","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University","place":["Cairo, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"El-Nabarawi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University","place":["Cairo, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal Anwar","family":"Taha","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology","place":["6th of October City, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehab","family":"Abdelmonem","sequence":"additional","affiliation":[{"name":"Department of Industrial Pharmacy, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology","place":["6th of October City, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"El-Refai","sequence":"additional","affiliation":[{"name":"Department of Industrial Pharmacy, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology","place":["6th of October City, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bfopcu.2012.07.001"},{"issue":"8","key":"e_1_3_2_3_1","first-page":"46","article-title":"Formulation of new sildenafil citrate-caffeine orally disintegrating tablets: in\u00a0vitro and in\u00a0vivo evaluation","volume":"3","author":"Abdel Halim S.","year":"2013","unstructured":"Abdel Halim S. 2013. Formulation of new sildenafil citrate-caffeine orally disintegrating tablets: in\u00a0vitro and in\u00a0vivo evaluation. J Pharm Res Opin. 3(8):46\u201363.","journal-title":"J Pharm Res Opin"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S327193"},{"issue":"6","key":"e_1_3_2_5_1","first-page":"532","article-title":"Formulation and evaluation of mouth dispersible tablets of simvastatine using novel excipents","volume":"6","author":"Abouzeid A","year":"2019","unstructured":"Abouzeid A, Essa E, Eldin E. 2019. Formulation and evaluation of mouth dispersible tablets of simvastatine using novel excipents. Biomed Eur Pharmaceut Sci. 6(6):532\u2013541.","journal-title":"Biomed Eur Pharmaceut Sci"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.102165"},{"issue":"1","key":"e_1_3_2_7_1","first-page":"265","article-title":"Evaluation of preparation methods for orally disintegrating tablets","volume":"9","author":"Akdag Y","year":"2020","unstructured":"Akdag Y, Gulsun T, Izat N, Cetin M, Oner L, Sahin S. 2020. Evaluation of preparation methods for orally disintegrating tablets. Medicine. 9(1):265\u2013269.","journal-title":"Medicine"},{"issue":"2","key":"e_1_3_2_8_1","first-page":"283","article-title":"Assessment of xanthan gum based sustained release matrix tablets containing highly water-soluble propranolol HCl","volume":"70","author":"Ali A","year":"2013","unstructured":"Ali A, Iqbal M, Akhtar N, Khan HMS, Ullah A, Uddin M, Khan MT. 2013. Assessment of xanthan gum based sustained release matrix tablets containing highly water-soluble propranolol HCl. Acta Pol Pharm. 70(2):283\u2013289.","journal-title":"Acta Pol Pharm"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.5958\/0974-360X.2019.00782.0"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.5530\/ijper.53.3.78"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2020.1826509"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.2478\/v10007-011-0020-8"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2017.11.006"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.3109\/10837450.2012.659258"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-018-1090-4"},{"key":"e_1_3_2_16_1","first-page":"6","volume-title":"The stationery office on behalf of the medicines and healthcare products regulatory agency (MHRA)","author":"British Pharmacopoeia","year":"2007","unstructured":"British Pharmacopoeia. 2007. The stationery office on behalf of the medicines and healthcare products regulatory agency (MHRA). London: British Pharmacopoeia; p. 6."},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.3109\/10837450.2012.710238"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2020.11.044"},{"issue":"5","key":"e_1_3_2_19_1","first-page":"250","article-title":"Orally disintegrating tablets: a review","volume":"1","author":"Chandan S","year":"2010","unstructured":"Chandan S, Varun D, Ashish G, Dabeer A, Ayaj A. 2010. Orally disintegrating tablets: a review. Int J Pharm Life Sci. 1(5):250\u2013256.","journal-title":"Int J Pharm Life Sci"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.2165\/00129784-200303020-00006"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2014.07.043"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.3109\/10837450.2013.862636"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(00)00569-6"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S126035"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.3109\/03639045.2014.972413"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2015.09.019"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.22159\/ijap.2019v11i1.29599"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.56899\/152.6A.08"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2018.07.025"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1081\/ddc-120016732"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2014.12.037"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.22159\/ijap.2023v15i4.47824"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.7324\/JAPS.2017.70109"},{"key":"e_1_3_2_34_1","volume-title":"Published by the directorate for the quality of medicines of the council of Europe (EDQM)","author":"European Pharmacopoeia","year":"2002","unstructured":"European Pharmacopoeia. 2002. Published by the directorate for the quality of medicines of the council of Europe (EDQM). Strasbourg: European Pharmacopoeia."},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0309894"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245482"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244646"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2016.04.006"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2023.2181747"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.2174\/187221108786241660"},{"issue":"4","key":"e_1_3_2_41_1","first-page":"227","article-title":"Improvement of nimesulide dissolution from solid dispersions containing croscarmellose sodium and Aerosil\u00ae 200","volume":"52","author":"Gohel MC","year":"2002","unstructured":"Gohel MC, Patel LD. 2002. Improvement of nimesulide dissolution from solid dispersions containing croscarmellose sodium and Aerosil\u00ae 200. Acta Pharmaceutica-Zagreb. 52(4):227\u2013242.","journal-title":"Acta Pharmaceutica-Zagreb"},{"issue":"7","key":"e_1_3_2_42_1","first-page":"389","article-title":"Preparation and evaluation of furosemide containing orally disintegrating tablets by direct compression","volume":"72","author":"Gulsun T","year":"2017","unstructured":"Gulsun T, Ozturk N, Kaynak MS, Vural I, Sahin S. 2017. Preparation and evaluation of furosemide containing orally disintegrating tablets by direct compression. Die Pharmazie-An Int J Pharmac Sci. 72(7):389\u2013394.","journal-title":"Die Pharmazie-An Int J Pharmac Sci"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-013-0030-8"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2005.11.013"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics3030440"},{"key":"e_1_3_2_46_1","first-page":"683","article-title":"Solubility and dissolution rate enhancement of olmesartan medoxomil by solid dispersion and development of orally disintegrating tablets","volume":"3","author":"Khandekar AK","year":"2014","unstructured":"Khandekar AK, Burade KB, Kanase SJ, Sawant GR, Narute DS, Sirsath SB. 2014. Solubility and dissolution rate enhancement of olmesartan medoxomil by solid dispersion and development of orally disintegrating tablets. World J Pharma Res. 3:683\u2013705.","journal-title":"World J Pharma Res"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2013.07.072"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.4274\/tjps.74946"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-014-0542-y"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3466.2001.tb00076.x"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2015.10.027"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.5958\/0974-360X.2019.00966.1"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-017-2129-z"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73135-8"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2005.11.027"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.18433\/j3pw2w"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.3109\/10717544.2016.1138340"},{"key":"e_1_3_2_58_1","first-page":"35","article-title":"Orally disintegrating tablets: formulation, preparation techniques and evaluation","author":"Nagar P","year":"2011","unstructured":"Nagar P, Singh K, Chauhan I, Verma M, Yasir M, Khan A, Sharma R, Gupta N. 2011. Orally disintegrating tablets: formulation, preparation techniques and evaluation. J Appl Pharmac Sci. 01(04): 35\u201345.","journal-title":"J Appl Pharmac Sci"},{"issue":"1","key":"e_1_3_2_59_1","first-page":"21","article-title":"Current developments in orally disintegrating tablet technology","volume":"2","author":"Nayak AK","year":"2011","unstructured":"Nayak AK, Manna K. 2011. Current developments in orally disintegrating tablet technology. J Pharmac Educ Res. 2(1):21.","journal-title":"J Pharmac Educ Res"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2003.08.001"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-014-0547-6"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.3109\/10837450.2014.882938"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1316374"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S87687"},{"issue":"3","key":"e_1_3_2_65_1","first-page":"937","article-title":"Appraisal of\u00a0the pharmacokinetic profile, histopathology, and stability studies of a fast dissolving oral film based on natural polysaccharide","volume":"35","author":"Sheikh FA","year":"2022","unstructured":"Sheikh FA, Aamir MN, Haseeb MT, Ajmal Shah M, Farid-Ul-Haq M, Alqarni M, Vargas-De-La-Cruz C, Blundell R. 2022. Appraisal of\u00a0the pharmacokinetic profile, histopathology, and stability studies of a fast dissolving oral film based on natural polysaccharide. Pak J Pharm Sci. 35(3):937\u2013944.","journal-title":"Pak J Pharm Sci"},{"issue":"1","key":"e_1_3_2_66_1","first-page":"343","article-title":"Formulation design, characterization and in\u00a0vitro drug release\u00a0study of orodispersible film comprising BCS class II drugs","volume":"33","author":"Sheikh FA","year":"2020","unstructured":"Sheikh FA, Aamir MN, Shah MA, Ali L, Anwer K, Javaid Z. 2020. Formulation design, characterization and in\u00a0vitro drug release\u00a0study of orodispersible film comprising BCS class II drugs. Pak J Pharm Sci. 33(1(Supplementary):343\u2013353.","journal-title":"Pak J Pharm Sci"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2009.04.005"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2011.02.005"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yasu.2023.04.009"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.c20-00480"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40780-020-00181-9"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.11336\/jjcrs.9.22"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.122838"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119153"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40005-014-0169-5"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.55.1119"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.5373"},{"issue":"4","key":"e_1_3_2_78_1","first-page":"3501","article-title":"Enhanced percutaneous absorption of cilostazol nanocrystals using aqueous gel patch systems and clarification of the absorption mechanism","volume":"15","author":"Yoshioka C","year":"2018","unstructured":"Yoshioka C, Ito Y, Nagai N. 2018b. Enhanced percutaneous absorption of cilostazol nanocrystals using aqueous gel patch systems and clarification of the absorption mechanism. Expe Therap Med. 15(4):3501\u20133508.","journal-title":"Expe Therap Med"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jngse.2016.12.026"}],"container-title":["Pharmaceutical Development and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10837450.2025.2472887","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T17:24:32Z","timestamp":1744392272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10837450.2025.2472887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":78,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3,16]]}},"alternative-id":["10.1080\/10837450.2025.2472887"],"URL":"https:\/\/doi.org\/10.1080\/10837450.2025.2472887","relation":{},"ISSN":["1083-7450","1097-9867"],"issn-type":[{"value":"1083-7450","type":"print"},{"value":"1097-9867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iphd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iphd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-12-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}